Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Flow Cytometric Assay Evaluated for Heparin-Induced Thrombocytopenia

By LabMedica International staff writers
Posted on 05 Jul 2016
Heparin-induced thrombocytopenia (HIT) is an immune-mediated thrombocytopenia associated with heparin therapy and the diagnosis consists of a combination of pretest probability and laboratory testing.

The routinely available laboratory antigen binding assays for the detection of specific antibodies have a low HIT-positive predictive value; therefore, to exclude false-positive results, one of the functional assays should be performed. More...
Functional assays evaluate the ability of heparin/platelet factor 4 (PF4) antibodies to activate the platelets.

Scientists at the University Medical Centre Ljubljana (Slovenia) investigated sera from adult patients, in which HIT was suspected, for the presence of HIT antibodies, using an immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) as the laboratory standard practice. After they set up the functional assay, 41 ELISA-positive serum samples were collected randomly for further testing.

The team tested the sera using an IgG-specific ELISA Kit (GTI Diagnostics, Inc., Waukesha, WI, USA). Platelet-activating antibodies were detected with a functional flow cytometric assay and analyzed on a FACSCalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). A functional heparin-induced platelet aggregation assay (HIPA) was also performed. Each test included diluted serum from the HIT patients as weak positive controls and serum from healthy donors as negative controls. To set up the cutoff of the flow cytometric assay, they analyzed a total of 100 samples, 25 HIT-positive and HIT-negative sera, each tested with different donor platelets.

The scientists found that of 41 ELISA positive serum samples, 14 were positive and 20 were negative by both flow cytometer and HIPA. Three other samples were discrepant between two assays: they were HIPA-positive and were negative with the flow cytometric assay. Conversely, four samples were flow cytometer positive and HIPA-negative. The samples included in this comparison were sera with detected anti-heparin/PF4 IgG antibodies with an OD greater than 0.4. The diagnostic specificity of the flow cytometric assay was calculated based on HIPA results and was 83%.

The authors concluded that performing this functional test after the screening assay could significantly improve the specificity of HIT testing as heparin/PF4 antibodies are often not clinically significant. The study was published in the June 2016 edition of the International Journal of Laboratory Hematology.

Related Links:
University Medical Centre Ljubljana
GTI Diagnostics
Becton Dickinson

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.